Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
US |
|
M
|
Master Style PCL
SET:MASTER
|
TH |
|
K
|
Kernel Holding SA
WSE:KER
|
UA |
|
Gitennes Exploration Inc
XTSX:GIT
|
CA |
|
Deckers Outdoor Corp
NYSE:DECK
|
US |
|
PCI Biotech Holding ASA
OSE:PCIB
|
NO |
|
Gazprom Gazoraspredeleniye Rostov-Na-Donu PAO
MOEX:RTGZ
|
RU |
|
Constellation Software Inc
TSX:CSU
|
CA |
|
Flow Traders NV
AEX:FLOW
|
NL |
Wall Street
Price Targets
AMPH Price Targets Summary
Amphastar Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
AMPH
is 29.58 USD
with a low forecast of 25.25 USD and a high forecast of 31.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AMPH's stock price target?
Price Target
29.58
USD
According to Wall Street analysts, the average 1-year price target for
AMPH
is 29.58 USD
with a low forecast of 25.25 USD and a high forecast of 31.5 USD.
What is Amphastar Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Amphastar Pharmaceuticals Inc's revenue is
14%.
The projected
CAGR
for the next 3 years is
5%.
What is Amphastar Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
17%
The
compound annual growth rate
of Amphastar Pharmaceuticals Inc's operating income for the next 3 years is
17%.
What is Amphastar Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
22%
For the last 14 years the
compound annual growth rate for
Amphastar Pharmaceuticals Inc's net income is
20%.
The projected
CAGR
for the next 3 years is
22%.
